Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.
In today’s ACT Brief, we examine how large de-identified datasets are reshaping trial design and site strategy, why global ...
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual ...
By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...
6don MSN
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show
In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...
Acquisition adds further specialist biostatistics, data management, and medical writing expertise to Evestia Clinical’s full-service offering and strengthens its presence in Germany and across Europe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results